Ignota Labs Strengthens Portfolio with Acquisition of Kronos’s Clinical-Stage Pipeline
Ignota Labs Strengthens Clinical Portfolio Through Acquisition of Kronos’s Development-Stage Assets Ignota Labs, an emerging pioneer in artificial intelligence–driven drug redevelopment, has announced the strategic acquisition of Kronos’s former clinical…
Automated Cell Processing Systems: Global Trends & Forecasts 2025–2035
Automated Cell Processing System Market Forecasts Set for Robust Growth Through 2035 Amid Rising Demand for Cell Therapies Automated Cell Processing System Market Industry Trends and Global Forecasts to 2035:…
Lymphoma ADC Market Outlook 2030: Pipeline, Patents, Prices & Clinical Trials
Global Lymphoma Antibody Drug Conjugates Market 2030: Pipeline, Patents, Prices, Approved Sales, and Clinical Trial Insights Lymphoma Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials…
Presto Dental Opens First Multi-Specialty Practice in Bridgeport, CT
Presto Dental Opens Flagship Multi-Specialty Practice in Bridgeport, Expanding Abra Health Group’s Connecticut Presence Presto Dental, a new and innovative dental brand affiliated with the Abra Health Group, has officially…
BUILT Biotechnologies Named Anchor Company at Commonwealth BioAccelerator Amid DNA Manufacturing Growth
BUILT Biotechnologies Named Anchor Company at Commonwealth BioAccelerator, Scaling DNA Manufacturing-as-a-Service to Meet Surging Demand BUILT Biotechnologies,a rapidly emerging leader in DNA Manufacturing-as-a-Service, has announced its selection as an anchor…
Molecular Diagnostics Market Forecast 2025–2035: Global Market to Reach $30.9B
Global Molecular Diagnostics Market Set to Reach $30.9 Billion by 2035: Industry Trends, Technologies, and Key Players Molecular Diagnostics Market Industry Trends and Global Forecasts to 2035: Distribution by Test…
Alpha Cognition Inc. Prices $35 Million Oversubscribed Public Offering of Common Shares
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares Alpha Cognition Inc. (Nasdaq: ACOG) (the “Company”), a commercial-stage biopharmaceutical company committed to advancing innovative therapies…
LEO Pharma Finalizes Acquisition of Spevigo
LEO Pharma a leading global company in medical dermatology LEO Pharma, a leading global company in medical dermatology, has successfully finalized its acquisition of Spevigo® from Boehringer Ingelheim, as officially…
FIRE1 Norm System Congestion Score Highlighted as Late-Breaking Science at HFSA 2025
FIRE1’s Norm System and Congestion Score Highlighted as Late-Breaking Science at HFSA 2025 FIRE1, a pioneering company in connected medical device solutions, has announced that its innovative heart failure management…
WINREVAIR™ Cuts PAH Clinical Worsening Risk by 76%
Merck Reports Clinical Positive Phase 3 HYPERION Trial Results for WINREVAIR™ (sotatercept-csrk) in Newly Diagnosed Pulmonary Arterial Hypertension Patients Merck known as MSD outside the United States and Canada, today…
Endeavor BioMedicines Shares Positive Phase 2a Taladegib Data
Endeavor BioMedicines Reports Positive Phase 2a Results for Taladegib in Idiopathic Pulmonary Fibrosis, Published in The Lancet Respiratory Medicine Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company focused on developing transformative…
HELIOS-B Phase 3: Vutrisiran Shows Fewer GI Events in ATTR-CM Patients
Alnylam Pharmaceuticals Reports HELIOS-B Phase 3 Findings: Vutrisiran Reduces Gastrointestinal Events in ATTR-CM Patients Alnylam Pharmaceuticals, Inc. , a global leader in RNA interference (RNAi) therapeutics, today unveiled new analyses…